Evidence map›Paper›PMID 36681674›Full record

ArticleNPJ biofilms and microbiomes2023

Antimicrobial potential of known and novel probiotics on in vitro periodontitis biofilms.

Wannes Van Holm, Rita Carvalho, Lize Delanghe, Tom Eilers, Naiera Zayed, Fabian Mermans, Kristel Bernaerts, Nico Boon, Ingmar Claes, Sarah Lebeer and 1 more

Abstract read
In one paragraph

Article in NPJ biofilms and microbiomes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Journal of oral microbiology · 2026
    Article
  11. Compatibility of toothpastes with probiotics for periodontal health: anFrontiers in cellular and infection microbiology · 2026
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Wannes Van HolmDepartment of Oral Health Sciences, University of Leuven (KU Leuven), Leuven, Belgium.
Rita CarvalhoDepartment of Oral Health Sciences, University of Leuven (KU Leuven), Leuven, Belgium.
Lize DelangheDepartment of Bioscience Engineering, University of Antwerp, Antwerp, Belgium.
Tom EilersDepartment of Bioscience Engineering, University of Antwerp, Antwerp, Belgium.ORCID 0000-0002-7509-2902
Naiera ZayedDepartment of Oral Health Sciences, University of Leuven (KU Leuven), Leuven, Belgium.ORCID 0000-0002-7773-8199
Fabian MermansCentre for Microbial Ecology and Technology (CMET), Ghent University (UGent), Gent, Belgium.ORCID 0000-0003-2997-2885
Kristel BernaertsBio- and Chemical Systems Technology, Reactor Engineering and Safety, Department of Chemical Engineering, University of Leuven (KU Leuven), Leuven, Belgium.
Nico BoonCentre for Microbial Ecology and Technology (CMET), Ghent University (UGent), Gent, Belgium.ORCID 0000-0002-7734-3103
Ingmar ClaesYUN NV, Niel, Belgium.ORCID 0000-0003-4209-4116
Sarah LebeerDepartment of Bioscience Engineering, University of Antwerp, Antwerp, Belgium.ORCID 0000-0002-9400-6918
Wim TeughelsDepartment of Oral Health Sciences, University of Leuven (KU Leuven), Leuven, Belgium. wim.teughels@kuleuven.be.ORCID 0000-0001-7675-5643

Funding

Agentschap Innoveren en Ondernemen (Flanders Innovation & Entrepreneurship) HBC.2020.2873EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) Lacto-Be 26850Fonds Wetenschappelijk Onderzoek (Research Foundation Flanders) G091218NKU Leuven (Katholieke Universiteit Leuven) C24/17/086
6 · The paper itself

Abstract

Several oral diseases are characterized by a shift within the oral microbiome towards a pathogenic, dysbiotic composition. Broad-spectrum antimicrobials are often part of patient care. However, because of the rising antibiotic resistance, alternatives are increasingly desirable. Alternatively, supplying beneficial species through probiotics is increasingly showing favorable results. Unfortunately, these probiotics are rarely evaluated comparatively. In this study, the in vitro effects of three known and three novel Lactobacillus strains, together with four novel Streptococcus salivarius strains were comparatively evaluated for antagonistic effects on proximal agar growth, antimicrobial properties of probiotic supernatant and the probiotic's effects on in vitro periodontal biofilms. Strain-specific effects were observed as differences in efficacy between genera and differences within genera. While some of the Lactobacillus candidates were able to reduce the periodontal pathobiont A. actinomycetemcomitans, the S. salivarius strains were not. However, the S. salivarius strains were more effective against periodontal pathobionts P. intermedia, P. gingivalis, and F. nucleatum. Vexingly, most of the Lactobacillus strains also negatively affected the prevalence of commensal species within the biofilms, while this was lower for S. salivarius strains. Both within lactobacilli and streptococci, some strains showed significantly more inhibition of the pathobionts, indicating the importance of proper strain selection. Additionally, some species showed reductions in non-target species, which can result in unexpected and unexplored effects on the whole microbiome.

Indexed as

Anti-Infective AgentsPeriodontitisProbioticsBiofilmsHumansLactobacillusAnti-Infective Agents

Identifiers

PMID36681674
PMCPMC9867767

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.